Tag Archives: D.A. Craig Watkins

The Business Journal – investor’s friend, or foe?

With Orchid Cellmark’s forensic evidence shenanigans unresolved, LabCorp issued a fifth extension of its purchase offer. Will The Business Journal follow the mainstream media in allowing the FTC to dither?  From: Susan Chandler Date: September 16, 2011 5:58:40 AM EDT To: mlevans@bizjournals.com Cc: “Alan J. Friedman” … Continue reading

Posted in Uncategorized | Tagged , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Dillon and Bennett, Orchid Cellmark and Feds – the good, the bad and the ugly

While the media maligns exoneree Bill Dillon and ignores Gary Bennett’s related frame-up, most of the hits on my blog are searches for information on Orchid Cellmark; it’s sale to LabCorp was pending. Investors aren’t looking for info on conviction … Continue reading

Posted in Uncategorized | Tagged , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment